statistiche ricercatore

GALLO, DANIELA

Distribuzione geografica

Continente	#
NA - Nord America	4.485
EU - Europa	2.101
AS - Asia	1.607
SA - Sud America	265
Continente sconosciuto - Info sul continente non disponibili	138
AF - Africa	45
OC - Oceania	14
AN - Antartide	1
Totale	8.656

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	4.356
IT - Italia	1.169
SG - Singapore	521
CN - Cina	380
VN - Vietnam	239
BR - Brasile	197
HK - Hong Kong	173
DE - Germania	158
SE - Svezia	146
UA - Ucraina	117
GB - Regno Unito	103
IE - Irlanda	80
FR - Francia	78
BD - Bangladesh	69
CA - Canada	66
TR - Turchia	63
RU - Federazione Russa	49
FI - Finlandia	47
IN - India	46
MX - Messico	37
JP - Giappone	28
NL - Olanda	26
CZ - Repubblica Ceca	24
PL - Polonia	22
AR - Argentina	20
AT - Austria	18
EC - Ecuador	17
NG - Nigeria	16
IQ - Iraq	15
BE - Belgio	14
MY - Malesia	12
AU - Australia	11
LT - Lituania	11
CL - Cile	10
ES - Italia	10
ID - Indonesia	10
AE - Emirati Arabi Uniti	8
KR - Corea	7
ZA - Sudafrica	7
PE - Perù	6
HN - Honduras	5
IL - Israele	5
VE - Venezuela	5
CO - Colombia	4
CR - Costa Rica	4
GP - Guadalupe	4
HU - Ungheria	4
PK - Pakistan	4
RO - Romania	4
TH - Thailandia	4
UZ - Uzbekistan	4
DZ - Algeria	3
JM - Giamaica	3
KG - Kirghizistan	3
MA - Marocco	3
NZ - Nuova Zelanda	3
PY - Paraguay	3
SA - Arabia Saudita	3
TW - Taiwan	3
AO - Angola	2
BA - Bosnia-Erzegovina	2
BG - Bulgaria	2
CG - Congo	2
CH - Svizzera	2
CI - Costa d'Avorio	2
EG - Egitto	2
GR - Grecia	2
KE - Kenya	2
PR - Porto Rico	2
PT - Portogallo	2
RS - Serbia	2
SI - Slovenia	2
TT - Trinidad e Tobago	2
UY - Uruguay	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
AQ - Antartide	1
BH - Bahrain	1
BW - Botswana	1
BY - Bielorussia	1
BZ - Belize	1
CW - ???statistics.table.value.countryCode.CW???	1
CY - Cipro	1
DO - Repubblica Dominicana	1
EE - Estonia	1
EU - Europa	1
GL - Groenlandia	1
GT - Guatemala	1
IS - Islanda	1
JO - Giordania	1
KZ - Kazakistan	1
LB - Libano	1
LU - Lussemburgo	1
LV - Lettonia	1
MD - Moldavia	1
ML - Mali	1
MM - Myanmar	1
MO - Macao, regione amministrativa speciale della Cina	1
NI - Nicaragua	1
NP - Nepal	1
Totale	8.513

Salva come PNG Salva come JPEG

Città	#
Milan	569
Ashburn	459
San Jose	372
Singapore	332
Dallas	328
Fairfield	261
Chandler	234
Woodbridge	182
Houston	178
Council Bluffs	173
Hong Kong	163
Beijing	108
Jacksonville	102
Cambridge	98
Los Angeles	97
Wilmington	96
Seattle	94
Ann Arbor	87
New York	80
Nyköping	80
Rome	75
Dublin	74
Princeton	67
Boardman	66
Como	65
Chicago	61
The Dalles	61
Dearborn	54
Hanoi	52
Ho Chi Minh City	49
Lauterbourg	49
Redmond	40
Santa Clara	38
Munich	34
Dong Ket	32
Phoenix	28
Buffalo	25
São Paulo	25
Mexico City	24
London	23
Naples	23
San Diego	23
Varese	23
Brno	21
Orem	21
Frankfurt am Main	20
Izmir	20
Toronto	20
Atlanta	19
Denver	19
Tokyo	19
Helsinki	18
Montreal	17
Warsaw	17
Washington	17
Guangzhou	16
Cavaria con Premezzo	15
Chennai	15
Tampa	15
Turku	15
Brooklyn	14
Brussels	14
Salt Lake City	14
Vienna	14
Elk Grove Village	12
Manchester	12
Ogden	12
San Francisco	12
Shanghai	11
Turin	11
Berlin	10
North Bergen	10
Poplar	10
Amsterdam	9
Nuremberg	9
Ottawa	9
Stockholm	9
Abuja	8
Boston	8
Falkenstein	8
Florence	8
Lagos	8
Las Vegas	8
Austin	7
Can Tho	7
Des Moines	7
Haiphong	7
Hefei	7
Istanbul	7
Kuala Lumpur	7
Kunming	7
Lancaster	7
Melbourne	7
Baghdad	6
Belo Horizonte	6
Columbus	6
Leinì	6
Newark	6
Querétaro	6
Sterling	6
Totale	5.760

Salva come PNG Salva come JPEG

Nome	#
Epidemiology, natural history, risk factors, and prevention of graves’ orbitopathy	272
Process to radioactive iodine treatment for Graves' hyperthyroidism: condemned or absolved?	270
The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study	270
Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management	263
Masked hypertension in newly diagnosed hypothyroidism: a pilot study	258
Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role?	250
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment	241
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review	231
Analysis of Graves’ disease from the origins to the recent historical evolution	226
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study	225
Outcome prediction of treatment of Graves' hyperthyroidism with antithyroid drugs	224
Pituitary apoplexy during pregnancy: A rare, but dangerous headache	223
Vitamin D status, enterovirus infection, and type 1 diabetes in Italian children/adolescents	219
Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe	219
Physical performance in newly diagnosed hypothyroidism: a pilot study	208
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center	197
The story of a vitamin for bone health that upgraded to hormone for systemic good health.	195
Gastric Xanthomatous Hyperplastic Polyps – Just an Incidental Endoscopic Finding?	193
Severità del Morbo di Basedow di prima diagnosi: ruolo dei linfociti Treg e dei micronutrienti. Dati preliminari di uno studio osservazionale pilota	182
A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease	180
Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study	178
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment	177
Change in newly diagnosed Graves' disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression	163
When primary hyperparathyroidism comes as good news	161
Is there a link between pain chronification, and allodynia and vitamin D deficiency in headache?	156
SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review	151
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	150
Negative impact of high body mass index on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells	148
Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis	146
Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher	145
Current perspective on the pathogenesis, predictive features and treatment of Graves’ disease	144
Dr Hashimoto and the discovery of autoimmune hypothyroidism	140
Assessment of the correlation between unipolar and bipolar depression, calcium levels, thyroid function, and inflammatory markers: a pilot cross-sectional study	140
COMPOSIZIONE CORPOREA E DINAMOMETRIA IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO AFFERENTI ALL’AMBULATORIO DI CONSULENZA NUTRIZIONALE DELLA S.S.D. BREAST UNIT – ASST SETTE LAGHI, VARESE	138
Evaluation of the Safety of Neauvia Stimulate Injectable Product in Patients with Autoimmune Thyroid Diseases Based on Histopathological Examinations and Retrospective Analysis of Medical Records	137
The interplay between thyroid and liver: implications for clinical practice	132
How Does Vitamin D Affect Immune Cells Crosstalk in Autoimmune Diseases?	126
Natural Killer Cells in Graves’ Disease: Increased Frequency but Impaired Degranulation Ability Compared to Healthy Controls	118
Liraglutide is an effective drug for the treatment of obesity also in real life	114
The discovery of TNF-α: a historical perspective	111
The old and the new in subacute thyroiditis: an integrative review	106
Regulatory T cells in the pathogenesis of graves' disease	102
Role of regulatory T cells in pathogenesis and therapeutics of Graves’ disease and Graves’ orbitopathy	98
Clinical and oncological outcomes in single-stage versus staged surgery for pediatric craniopharyngiomas: a multicenter retrospective study	96
Predicting the Risk of Graves Disease Relapse: Commentary on "Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease"	91
Treatment of moderate-to-severe and active Graves’ orbitopathy: a step forward from the OPTIC study	89
Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors	84
Management of Graves' hyperthyroidism: present and future	82
Chapter 30 - Autoimmune thyroid diseases	76
Meccanismi di azione dei principali farmaci utilizzati nel trattamento dei carcinomi tiroidei	75
Editorial: Immunocellular mechanisms and endocrine organs	67
Impact of thyroid disorders on flow-mediated dilation: a systematic review and meta-analysis	63
Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves' orbitopathy	49
Graves' orbitopathy following Alemtuzumab treatment for multiple sclerosis: a systematic review and real-world insights	43
Surgical considerations for adult Graves’ disease: a narrative review of indications, perioperative challenges and postoperative outcomes	34
Nutritional Approach in Thyroid Disease: Reality and Myths to Dispel	33
Smoking and the thyroid	25
null	22
Totale	8.656

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	37.172
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	37.172

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	377	0	0	0	20	25	19	60	26	70	87	24	46
2022/2023	668	58	64	60	66	58	121	9	87	63	25	27	30
2023/2024	1.005	141	138	129	174	167	114	6	13	21	29	12	61
2024/2025	1.009	12	13	107	74	47	45	54	70	76	81	181	249
2025/2026	3.008	235	308	236	440	294	147	511	176	218	215	121	107
2026/2027	918	105	193	279	341	0	0	0	0	0	0	0	0
Totale													8.656